129 related articles for article (PubMed ID: 24756983)
21. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
22. Pilot study of etanercept in patients with refractory juvenile dermatomyositis.
Rouster-Stevens KA; Ferguson L; Morgan G; Huang CC; Pachman LM
Arthritis Care Res (Hoboken); 2014 May; 66(5):783-7. PubMed ID: 24127327
[TBL] [Abstract][Full Text] [Related]
23. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
[TBL] [Abstract][Full Text] [Related]
24. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
Cooper MA; Willingham DL; Brown DE; French AR; Shih FF; White AJ
Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in adults with juvenile-onset dermatomyositis: a case-control study.
Tollisen A; Sanner H; Flatø B; Wahl AK
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1020-7. PubMed ID: 22328537
[TBL] [Abstract][Full Text] [Related]
26. Decreased aerobic capacity in children with juvenile dermatomyositis.
Hicks JE; Drinkard B; Summers RM; Rider LG
Arthritis Rheum; 2002 Apr; 47(2):118-23. PubMed ID: 11954004
[TBL] [Abstract][Full Text] [Related]
27. von Willebrand factor in juvenile dermatomyositis.
Bloom BJ; Tucker LB; Miller LC; Schaller JG
J Rheumatol; 1995 Feb; 22(2):320-5. PubMed ID: 7738956
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
[TBL] [Abstract][Full Text] [Related]
29. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
30. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.
de Jager W; Hoppenreijs EP; Wulffraat NM; Wedderburn LR; Kuis W; Prakken BJ
Ann Rheum Dis; 2007 May; 66(5):589-98. PubMed ID: 17170049
[TBL] [Abstract][Full Text] [Related]
31. Lack of achievement of a full score on the childhood myositis assessment scale by healthy four-year-olds and those recovering from juvenile dermatomyositis.
Quiñones R; Morgan GA; Amoruso M; Field R; Huang CC; Pachman LM
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1697-701. PubMed ID: 23666925
[TBL] [Abstract][Full Text] [Related]
32. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
[TBL] [Abstract][Full Text] [Related]
33. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
[TBL] [Abstract][Full Text] [Related]
34. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
Miles L; Bove KE; Lovell D; Wargula JC; Bukulmez H; Shao M; Salisbury S; Bean JA
Arthritis Rheum; 2007 Oct; 57(7):1183-91. PubMed ID: 17907236
[TBL] [Abstract][Full Text] [Related]
35. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis.
De Benedetti F; De Amici M; Aramini L; Ruperto N; Martini A
Arch Dis Child; 1993 Aug; 69(2):232-5. PubMed ID: 8215528
[TBL] [Abstract][Full Text] [Related]
36. Study of subcutaneous fat in children with juvenile dermatomyositis.
Verma S; Singh S; Bhalla AK; Khullar M
Arthritis Rheum; 2006 Aug; 55(4):564-8. PubMed ID: 16874777
[TBL] [Abstract][Full Text] [Related]
37. Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
Huber AM; Dugan EM; Lachenbruch PA; Feldman BM; Perez MD; Zemel LS; Lindsley CB; Rennebohm RM; Wallace CA; Passo MH; Reed AM; Bowyer SL; Ballinger SH; Miller FW; Rider LG;
Arthritis Rheum; 2008 Feb; 59(2):214-21. PubMed ID: 18240194
[TBL] [Abstract][Full Text] [Related]
38. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
39. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study.
Ruperto N; Ravelli A; Pistorio A; Ferriani V; Calvo I; Ganser G; Brunner J; Dannecker G; Silva CA; Stanevicha V; Cate RT; van Suijlekom-Smit LW; Voygioyka O; Fischbach M; Foeldvari I; Hilario O; Modesto C; Saurenmann RK; Sauvain MJ; Scheibel I; Sommelet D; Tambic-Bukovac L; Barcellona R; Brik R; Ehl S; Jovanovic M; Rovensky J; Bagnasco F; Lovell DJ; Martini A; ;
Arthritis Rheum; 2008 Jan; 59(1):4-13. PubMed ID: 18163404
[TBL] [Abstract][Full Text] [Related]
40. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
Bjørnhart B; Svenningsen P; Gudbrandsdottir S; Zak M; Nielsen S; Bendtzen K; Müller K
Int Immunopharmacol; 2005 Jan; 5(1):73-7. PubMed ID: 15589462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
